SGLT2 Inhibitors in Cardiovascular Disease: Mechanisms, Clinical Evidence and Evolving Therapeutic Applications. (2023). Global Journal of Medical and Pharmaceutical Sciences, 1(4), 19-30. http://www.globapc.com/index.php/gjmps/article/view/33